Robotic surgery to the test provided for colorectal cancer

Current article ratings:
Patients / public:healthcare Prof:
A robot system for improving the quality of the "keyhole" intestinal cancer surgery is for the first time applied to the test.

The global study, led by the University of Leeds, will show whether robot makes support remove it easier, intestinal tumors with laparoscopic or "Keyhole" techniques and whether this approach less likely to get cancer is back. The study will also show whether surgeons give robot 'helping hand' means the patients of less gut and suffering fewer complications spend time in the hospital after minimally invasive surgery.

Remove many operations, intestine, which can be done now tumors with minimally invasive surgery, inserted while the surgeons use elongated special instruments through small holes in the abdominal wall, to cancer to remove. In the hands of an experienced surgeon surgery as well as open surgery for the treatment of colorectal cancer is invasive. Patients who removed their tumors via keyhole surgery also benefit from shorter hospital stays and faster recovery times.

Remove a minimal invasive surgery with colon cancer, however, is a demanding procedure. Sometimes, surgeons have to the open surgery half way through the operation and set a large cut in the stomach of patients get to go to the cancer.

To fix this, robotic systems developed, that take out techniques easier for the surgeon to see and intestine cancer with keyhole. These systems can sit within a few meters away from the patient surgeon and watch enlarged video images of the operation. Through these images, the surgeon will carefully then precise hand movements a series of robotic surgical instruments into the body of the patient, the cancer remove controlled.

Researchers and surgeons now want to find out what difference of Robotics in practice to make. To do this, they are compare, what happens with intestinal cancer patients to undergo robot-assisted minimally invasive surgery against those who standard laparoscopic surgery.

David Jayne, senior lecturer in surgery at the University of Leeds and Chief Investigator for the ROLARR (Robotics versus laparoscopic surgery), attempt, said: "it is very exciting to see the emergence of robotic surgery and I am confident that such systems of real benefit to patients with colorectal cancer." However, it is extremely important that the value of the robot help to properly interpret. "Surgeon, patients and care providers in the health sector need to know, this technology which make difference of this expensive and specialist - is what will show in this study."

Professor Julia Brown, Director of the clinical studies which unit, University of Leeds research said: "we look forward to our track record in the evaluation of building are new surgical procedures and expand in a worldwide review."

The first patients to participate in this study of the surgical technology of the next generation are now recruited. Finally, the study will include 400 patients in more than 20 centers in Asia, Europe and the United States.

The study of ROLARR is managed by the University of Leeds clinical trials research unit (CTRU), part of the University School of medicine. The study is a partnership between the University of Leeds and Leeds teaching hospitals NHS Trust.

The work is by a research grant, awarded by the efficacy and mechanism evaluation (EME) program, which is funded by medical research Council (MRC) and managed research (NIHR) funded by the National Institute of health. Additional financial support was provided by the University of Leeds biomedical and Health Research Centre (BHRC).

Notes

1. Trial ROLARR work in the CLASICC follows a landmark study, also conducted by researchers of the University of Leeds and research unit, coordinated by the clinical trials that helped to change attitudes and practice towards laparoscopic surgery for colorectal cancer. See under DG Jayne et al., "five-year follow up of the Medical Research Council CLASICC study of laparoscopically supports in contrast to open surgery for colorectal cancer ', British Journal of surgery, 97(11), November 2010. (see here)."

2. One based research UK's largest medicine, health and bioscience, the University of Leeds offers world-leading research in medical technology, cancer, heart circulation studies, epidemiology, molecular genetics, Musculoskeletal Medicine, dentistry, psychology and applied health. The lives of people around the world are transforming treatments with diseases such as diabetes, HIV, tuberculosis and malaria and developed initiatives in Leeds.

The University of Leeds clinical trials research unit (CTRU) is one of the largest units, clinical studies in Europe with a large portfolio of clinical studies and associated methodological research. In view of the quality of your portfolio, the CTRU is a National Cancer Research Institute accredited and UKCRC registered CTU.

Source:
Biomedical and Health Research Centre (BHRC)
Efficacy and mechanism evaluation (EME)
NIHR
Medical Research Council
University of Leeds